Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. VINGE ADVISES TRAVEAS ON MERGER WITH EVERYSPORT
Mandate

VINGE ADVISES TRAVEAS ON MERGER WITH EVERYSPORT

November 24, 2015

Vinge and Navia Law have advised Traveas (listed on Aktietorget) in connection with the merger with a group of sports media companies packaged and consolidated under Everysport AB, which includes several popular sports media websites such as HockeySverige.se, Fotbolldirekt.se, Eliteprospects.com, Everysport.com and Goalwire.se. The merger is proposed to be effected through an issue in kind in Traveas directed to Everysport’s shareholders. The transaction is, among others things, conditional upon the adoption of the relevant resolutions at a general meeting of Traveas.

Vinge’s team consisted of partners Johan Winnerblad and Dain Hård Nevonen.

Related

Vinge has advised Hansa Biopharma in connection with entering into a financing agreement

 Vinge has advised Hansa Biopharma AB (publ), a commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions, listed on Nasdaq Stockholm, in connection with a U.S. convertible note purchase agreement comprising USD 30 million aggregate principal amount of unsecured convertible senior notes.
March 23, 2026

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

 Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

 Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026